Skip to main content
letter
. 2011 Aug;55(8):3961–3963. doi: 10.1128/AAC.00438-11

Table 1.

In vitro susceptibilities of 138 commonly isolated nonfermenting Gram-negative bacillus isolates to tigecycline and other tetracyclines

Species (no. of isolates) Drug MIC (μg/ml)
Range Breakpoint interpretationa
MIC50 MIC90
S I R
Achromobacter spp. (33) Tetracycline 2–256 ≤4 8 ≥16 256 256
Doxycycline 0.5–64 ≤4 8 ≥16 16 64
Minocycline 0.5–16 ≤4 8 ≥16 2 8
Tigecyclineb 0.5–4 ≤2 4 ≥8 2 4
Alcaligenes faecalis (11) Tetracycline 4–32 ≤4 8 ≥16 8 16
Doxycycline 2–16 ≤4 8 ≥16 2 8
Minocycline 1–8 ≤4 8 ≥16 2 8
Tigecyclineb 1–8 ≤2 4 ≥8 2 4
Burkholderia cepacia complex (21) Tetracycline 0.03–256 ≤4 8 ≥16 16 64
Doxycycline 0.06–16 ≤4 8 ≥16 4 4
Minocyclinec 0.03–4 ≤4 8 ≥16 1 2
Tigecyclineb 0.03–2 ≤2 4 ≥8 0.5 2
Chryseobacterium gleum-indologenes (11) Tetracycline 0.06–32 ≤4 8 ≥16 8 32
Doxycycline 0.125–16 ≤4 8 ≥16 1 8
Minocycline 0.03–2 ≤4 8 ≥16 0.25 1
Tigecyclineb 0.03–4 ≤2 4 ≥8 1 4
Elizabethkingia meningoseptica (15) Tetracycline 2–128 ≤4 8 ≥16 32 64
Doxycycline 1–32 ≤4 8 ≥16 2 4
Minocycline 0.06–2 ≤4 8 ≥16 0.25 0.5
Tigecyclineb 0.25–8 ≤2 4 ≥8 2 8
Stenotrophomonas maltophilia (26) Tetracycline 0.5–64 ≤4 8 ≥16 8 16
Doxycycline 1–4 ≤4 8 ≥16 2 2
Minocyclined 0.25–2 ≤4 8 ≥16 0.25 0.5
Tigecyclineb 0.125–8 ≤2 4 ≥8 0.5 2
Pseudomonas putida (11) Tetracycline 0.125–256 ≤4 8 ≥16 2 16
Doxycycline 0.06–128 ≤4 8 ≥16 4 32
Minocycline 0.06–32 ≤4 8 ≥16 2 16
Tigecyclineb 0.25–16 ≤2 4 ≥8 2 8
Pseudomonas stutzeri group (10) Tetracycline 0.125–8 ≤4 8 ≥16 0.5 4
Doxycycline 0.25–8 ≤4 8 ≥16 2 8
Minocycline 0.5–8 ≤4 8 ≥16 1 4
Tigecyclineb 0.06–4 ≤2 4 ≥8 0.25 2
a

S, sensitive; I, intermediate; R, resistant. CLSI categories for other non-Enterobacteriaceae for tetracycline, doxycycline, and minocycline were used (susceptibility at 4 μg/ml, intermediacy at 8 μg/ml, and resistance at 16 μg/ml).

b

Breakpoint recommended by the U.S. Food and Drug Administration when testing Enterobacteriaceae for tigecycline (susceptibility at 2 μg/ml, intermediacy at 4 μg/ml, and resistance at 8 μg/ml).

c

Burkholderia cepacia CLSI breakpoint recommended for minocycline.

d

Stenotrophomonas maltophilia CLSI breakpoint recommended for minocycline.